Clinical Trial

The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.

Study acronym: DOSCA-2
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about the long-term effects of radiotherapy for people who were treated for non-melanoma skin cancer (NMSC) in the head and neck area. The study focuses on adults who finished radiotherapy at least two years ago. The main questions we aim to answer are: How satisfied are participants with the cosmetic result of their treatment? What skin changes do healthcare professionals observe at the treated area? How many participants have experienced a recurrence or developed a new skin cancer, since treatment? Participants will be invited to: Attend one extra hospital visit at least two years after they finished radiotherapy Answer a short questionnaire about their cosmetic satisfaction Have their skin examined, including photos and dermatoscopy The results may help improve future treatment guidelines for people with non-melanoma skin cancer.professional, and any local recurrences will be identified through national health registries. This nationwide study (DOSCA-2) will provide real-world data to help guide future treatment recommendations for NMSC.
Trial Details
NCT Number NCT07347392
Lead Sponsor University of Aarhus
Collaborators: Aarhus University Hospital, Aalborg University Hospital, Vejle Hospital, Rigshospitalet, Denmark, Copenhagen University Hospital at Herlev, Danish Cancer Society
Conditions Non-Melanoma Skin Cancer (NMSC), Basal Cell Carcinoma of Skin, Squamous Cell Carcinoma of the Skin
Enrollment 2,900 participants
Start Date 2025-12-15
Primary Completion 2029-09-01 (estimated)
Study Completion 2029-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-16